FDA.reportPublic FDA data

Application 214219

Type
ANDA
Sponsor
RICONPHARMA LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TRIAZOLAMTRIAZOLAMTABLET;ORAL0.125MGNoNo
002TRIAZOLAMTRIAZOLAMTABLET;ORAL0.25MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50742-645TriazolamTriazolamIngenus Pharmaceuticals, LLCANDACurrent
50742-645TriazolamTriazolamIngenus Pharmaceuticals, LLCANDACurrent
50742-645TriazolamTriazolamIngenus Pharmaceuticals, LLCANDACurrent
50742-645TriazolamTriazolamIngenus Pharmaceuticals, LLCANDACurrent
50742-646TriazolamTriazolamIngenus Pharmaceuticals, LLCANDACurrent
50742-646TriazolamTriazolamIngenus Pharmaceuticals, LLCANDACurrent
50742-646TriazolamTriazolamIngenus Pharmaceuticals, LLCANDACurrent
50742-646TriazolamTriazolamIngenus Pharmaceuticals, LLCANDACurrent
71335-1876TriazolamTriazolamBryant Ranch PrepackANDACurrent
71335-1876TriazolamTriazolamBryant Ranch PrepackANDACurrent